CCM
PAHC icon

Cadence Capital Management’s Phibro Animal Health PAHC Stock Holding History

Cadence Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,520
Closed -$617K – 640
2015
Q3 		$617K Sell
19,520
-73,800
-79% -$2.69M 0.04% 415
2015
Q2 		$3.63M Buy
+93,320
New +$3.22M 0.2% 132

Other funds holding PAHC

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cadence Capital Management's PAHC Position: Q4 2015 in Review

Cadence Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2015, closing a stake of 19,520 shares — an estimated $617K sold.

Cadence Capital Management first reported a position in PAHC in Q2 2015 and held it in 2 quarters. The position peaked at $3.63M in Q2 2015. 124 funds tracked by Wall St. Rank hold PAHC as of Q4 2015.

  • Cadence Capital Management reported no remaining Phibro Animal Health position as of Q4 2015 after selling out during the quarter.
  • Cadence Capital Management sold 19,520 Phibro Animal Health shares in Q4 2015, an estimated $617K.
  • Cadence Capital Management first reported a position in Phibro Animal Health in Q2 2015 and held it in 2 quarters.
  • Cadence Capital Management's Phibro Animal Health position peaked at $3.63M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2015.

Based on Cadence Capital Management's 13F filing for Q4 2015, filed 3 Feb 2016.